Does herve have any efficacy Ar apricative marker for the ablative bone marrow transplantation?
CHILDS: Unfortunately, that’s a very, very good question. Unfortunately, we have not been able to go back and do that type of correlation because the majority of the patients we don’t have fresh tumor samples to most patients, the only thing we have is pair fin samples. And it’s been very, very difficult toasmlify from RNA this endogenous retrovirus. We only get pieces. I think that would be a very, very important experiment to do because if we could find that there was a correlation with expression and response and that would help stratify which patients that we would put on the protocol. One of the things that we hope to do in the future is to be able to potentially detect Humoral responses to antigen that is are derived from this human endogenous retrovirus and if we can do that, then perhaps we could correlate antibody responses with response to either transplant or maybe even response to Interleukin 2. It’s still not understood why some patients with clear cell carcinoma respond t
